This RSA section is an unofficial mirror, is not legal advice, and may be incomplete, outdated, or incorrectly processed.

RSA 326-B:31 · Continuing Education

Title: XXX: OCCUPATIONS AND PROFESSIONS
Chapter: 326-B · NURSE PRACTICE ACT
Status: current
Official source linked: Yes

Official source Copy section link

326-B:31 Continuing Education. – Applicants for license renewal and license reinstatement shall complete continuing education as follows:

Copy link

An LNA shall complete 12 hours of continuing education in programs approved by the board each year, provided that licensees who hold a certificate of medication administration shall complete at least 4 hours of those 12 hours in medication administration.

Copy link

II.

An LPN or an RN shall complete 30 hours of continuing education every 2 years.

Copy link

III.

An APRN, in addition to the continuing education requirements to renew or reinstate a license as an RN, shall complete 30 hours of continuing education every 2 years, 20 hours of which shall be specific to the specialty for which renewal or reinstatement is sought, and 5 hours of which shall be training in pharmacology appropriate to the specialty for which license renewal or reinstatement is sought.

Copy link

IV.

A CALMA shall complete 8 hours of continuing education relative to medication administration in programs approved by the board every 2 years. Source. 2005, 293:1. 2009, 54:4, eff. July 21, 2009. 2024, 327:110, eff. July 1, 2024; 344:5, eff. Oct. 1, 2024.

Copy link

Source note

Source. 2005, 293:1. 2009, 54:4, eff. July 21, 2009. 2024, 327:110, eff. July 1, 2024; 344:5, eff. Oct. 1, 2024.

Source history

2005, 293:1
2009, 54:4, eff. July 21, 2009
2024, 327:110, eff. July 1, 2024; 344:5, eff. Oct. 1, 2024

Related materials

Bill relationships

2026 HB1321 reference
cian licensed under this chapter, a physician associate licensed under RSA 328-D acting within the scope of their practice, or an advanced practice registered nurse licensed under RSA 326-B acting within the scope of their practice. 329:56 Administration of Elective Intravenous Therapy. Elective intravenous therapy may only be administered by a physician licensed under this chapter, a physician associ
2026 HB1796 reference · effective 2027-01-01
rgeon or osteopathic physician and surgeon licensed pursuant to RSA 329, a physician associate licensed pursuant to RSA 328-D, or an advanced practice registered nurse pursuant to RSA 326-B, who is registered by the department to recommend treatment with psilocybin. XX. “Qualified therapy provider” means a physician and surgeon or osteopathic physician and surgeon licensed pursuant to RSA 329, a physic
2026 HB1796-FN reference · effective 2027-01-01
rgeon or osteopathic physician and surgeon licensed pursuant to RSA 329, a physician associate licensed pursuant to RSA 328-D, or an advanced practice registered nurse pursuant to RSA 326-B, who is registered by the department to recommend treatment with psilocybin. XX. “Qualified therapy provider” means a physician and surgeon or osteopathic physician and surgeon licensed pursuant to RSA 329, a physic
2026 SB453 reference
d by the commissioner or his designee shall be for a period not to exceed 2 years; except in any case where a licensed physician, advanced practice registered nurse licensed under RSA 326-B, or physician associate licensed under RSA 329-D documents a lasting medical necessity, in which case the waiver shall be for a period not to exceed 4 years. The applicant may reapply for the waiver before such period e
2025 HB254 reference
tions to be used in medical aid in dying: (1) A physician licensed pursuant to RSA 329; (2) An osteopathic physician licensed pursuant to RSA 329; (3) An advanced practice registered nurse licensed pursuant to RSA 326-B; or (4) A pharmacist licensed pursuant to RSA 318; provided, however, that a pharmacist shall not qualify as an attending health care provider under RSA 137-M:1, II or as a consulting health care provider unde